OrganoTherapeutics is a spin-off project from the University of Luxembourg. OrganoTherapeutics use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen for novel compounds which can be therapeutic for different patient sub-groups.

We use a set of computational AI tools to perform deep phenotyping of our models to better detect cellular defects and their rescue following compound treatments.